EPHA2 and cancer: This because it showed (near) perfect mutual exclusivity with the well-known drivers PIK3CA, GAB2, PAK1 and RPS6KB and all members of the PI3K pathway known to act downstream of EPHA2. These results were confirmed by the visualization of the mutual exclusivity patterns at pan-cancer level (Fig. 4).